Articles Archives - Page 528 of 768

WednesdaySep 23, 2020 1:51 pm

United Bid to Liberalize Use of Psilocybin Strengthens

Leading UK scientists, policy group call for rescheduling of psilocybin amid looming mental health crisis Sent to the Home Office with statements of support from leading scientists, paper urges for psilocybin use on a research-only model Cybin Corp. to capitalize on international expansion of psilocybin use as a company active in both research, nonclinical spaces The United Kingdom (“UK”) is joining other countries, including Canada, in a push to facilitate the wider use of psilocybin, a naturally occurring compound found in mushrooms. Focusing on psychedelic and nutraceutical products, Cybin Corp. is poised to leverage the growing global momentum the compound is…

WednesdaySep 23, 2020 12:53 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Mines Investment-building Opportunity for Brain Tumor-Targeting Drug Candidate at Annual Conference

CNS Pharmaceuticals is a clinical-stage biotechnology company developing therapies to combat aggressive cancers of the brain and central nervous system The company will be applying for approval to launch Phase II trials in the first quarter of 2021 for its leading drug candidate, Berubicin, which targets glioblastoma multiforme (“GBM”) brain cancer CNS Pharmaceuticals CEO addressed the company’s achievements and its vision for Berubicin development during the recent 22nd annual Global Investment Conference sponsored by H.C. Wainwright & Co. C. Wainwright is a full-service investment bank focused on capital markets and equity research in market sectors that hinge on industries encompassing…

WednesdaySep 23, 2020 11:45 am

SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Publishes Crucial Insights into US Consumer Trends Amid Pandemic

SRAX’s BIGtoken’s platform allows companies to gain transparent, instant insights from platform’s 16.7+ million subscribers BIGtoken surveyed US user-base in early April and again in August in bid to track changes in US consumer behavior Actionable insights gleaned from survey reveal US citizens’ consumption habits SRAX Inc. (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has recently published the results of a series of surveys carried out by BIGtoken, its proprietary consumer insights platform. BIGtoken enables its platform’s user base of over 16.7 million consumers to both own their data and monetize it in an…

TuesdaySep 22, 2020 3:00 pm

Sustainable Green Team Ltd. (SGTM) Expanding into Midwest, Meeting Increasing Demand for Environmentally Friendly Solutions

SGTM entered packaging agreement with Old Castle Lawn & Garden to supply large Midwest home improvement chains Old Castle Lawn & Garden parent company CRH employs 80,300 people at more than 3,100 locations across 30 countries SGTM dispatched team to assess damage from Hurricane Laura, one of the strongest in history SGTMS’s Q2 results nearly doubled from Q1 to $12.3 million in revenue, $3.4 million in gross profit As nationwide demand for environmentally sustainable solutions for waste increases, Sustainable Green Team (OTC: SGTM) –a leading provider of environmentally beneficial solutions for tree and storm waste disposal—continues to expand its footprint…

TuesdaySep 22, 2020 1:29 pm

PacRoots Cannabis Corp. (CSE: PACR) Reveals Progress of Planting on 100-acre CBD Hemp Site in British Columbia

PacRoots Cannabis entered into a 60:40 joint-venture with Rock Creek Farms to plant premium hemp CBD plants on 100-acre site in British Columbia As of mid-June, approximately 130,000 seedlings have been planted with initial harvest set to take place October 15, 2020 Initial harvest expected to yield between 500,000-700,000 pounds of biomass Totality of harvest yield is already under sale to local processor at fair market rate Proceeds from JV will initially go towards repaying PacRoots’ capital contribution with profits thereafter split along terms of the JV PacRoots Cannabis (CSE: PACR), a Canada-based company dedicated towards producing premium-quality strains and…

TuesdaySep 22, 2020 1:06 pm

Mobius Interactive Ltd., Leading iGaming Provider Partner to Build Worldwide Network of Dedicated Gamers

Mobius partners with UltraPlay to enhance customer engagement UltraPlay at forefront of iGaming industry, provides widest eSports betting coverage in industry Partnership is clear indication of Mobius’s strong position coming straight out of gate Mobius Interactive, an online gaming operator providing a variety of unique offerings catering to diverse demographic groups, has partnered with UltraPlay, a leading eSports and iGaming platform, to attract a global network of high-net-worth gamers. The two companies are working together to enhance customer engagement through the use of loyalty and gamification programs. UltraPlay, an advanced-betting solutions provider, has been at the forefront of the iGaming…

MondaySep 21, 2020 3:08 pm

Trxade Group, Inc. (NASDAQ: MEDS) Showcases Prescription Affordability Efforts During Virtual Investor Summit

Pharmaceutical industry services provider Trxade Group Inc. presented an overview of the company’s structure and strategy at this month’s LD 500 invitational microcap investor summit The investor summit was a virtual gathering place during the ongoing pandemic, providing brand and industry information through webcasts to more than 20,000 attendees representing hundreds of companies Trxade Group is dedicated to helping its growing network of independent pharmacies compete with big box chains through a supply chain trading platform that delivers transparent product pricing and availability information Trxade Group is also developing its nascent B2C operations with Telehealth services that link home-bound or…

MondaySep 21, 2020 1:49 pm

KBL Merger Corp. IV (NASDAQ: KBLM) (NASDAQ: KBLMR) (NASDAQ: KBLMW) Fulfilling IPO Goal Through Merger With 180 Life Sciences Corp.

KBL Merger Corp. IV is set to finalize the acquisition of 180 Life Sciences Corp. during Q4 2020 180 Life Sciences Corp. has several ongoing programs at different stages of development, with the leading candidate in Phase 2b/3, helping mitigate the risks involved with its drug development The merger with 180 Life Sciences will enable KBL Merger Corp. IV to enter a market expected to double in size by 2027 180 Life Sciences is growing its patent portfolio through several preclinical studies beginning in two additional areas of inflammatory novel drug studies KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp.…

Site Search

Company Search

Category: Articles